PTAB Upholds Vimovo Patent Claims Challenged By Lupin
Pozen Inc. fended off further challenges to patents covering its arthritis and ulcer drug Vimovo on Tuesday, when the Patent Trial and Appeal Board decided that Lupin Ltd. had not shown...To view the full article, register now.
Already a subscriber? Click here to view full article